Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

Somite, an AI-native TechBio company building the first universal virtual cell-signaling model, today announced its new identity, Cellular Intelligence. This rebrand reflects the company's vision to ...

Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...

The mystery of early embryonic communication is starting to be unraveled thanks to a new stem cell-based model.